| High tech enterprises are the main manifestation of a country’s market competitiveness and high-quality economic development.The important driving force for the development of high-tech enterprises is research and development investment.Among all industry enterprises in China,high-tech enterprises have the highest dependence on innovation,and research and development can provide a continuous stream of fresh blood for the sustained growth of high-tech enterprises.However,there are phased issues in the development of high-tech enterprises in China,such as high innovation risks,slow fund recovery cycles,and a shortage of talents.This has led to a certain gap in the innovation enthusiasm and research and development capabilities of high-tech enterprises in China compared to developed countries in the world.Therefore,in order to improve the country’s innovation capacity and international competitiveness,the Chinese government needs to fully leverage the regulatory function of taxation,promote high-tech enterprises to increase research and development investment,and become bigger and stronger.Therefore,since the implementation of large-scale tax and fee reductions in 2018,the most eye-catching is the launch of a "package" of preferential policies to support technological innovation.This article follows the writing approach of paper background,theoretical foundation,current situation analysis,case analysis,conclusions and suggestions to conduct a deep research on the effectiveness of China’s tax reduction and fee reduction policies in stimulating R&D investment in high-tech enterprises.Taking Fosun Pharmaceutical as a case study and combining data from enterprises in the past decade,this article analyzes the impact.On the basis of organizing existing research literature and elaborating relevant theories by domestic and foreign scholars,this article lays the theoretical foundation for subsequent analysis and research.Subsequently,it will introduce the implementation of China’s tax and fee reduction policies,the characteristics and problems of high-tech enterprise R&D investment,and analyze the incentive path of tax and fee reduction for high-tech enterprise R&D investment.In the next section,conduct a case study.Introduce the R&D organization management,tax burden,and tax incentives enjoyed by Fosun Pharmaceutical.Based on theoretical basis and incentive path analysis,introduce the incentive path and effect of tax reduction and fee reduction on the R&D investment of the case company from aspects such as R&D investment risk,financing constraints,R&D investment intensity,and R&D personnel structure.Subsequently,the principal component analysis method will be introduced to comprehensively evaluate the incentive effect of tax incentives on enterprise research and development investment.Finally,the case study results are summarized to provide targeted suggestions for high-tech enterprises to fully play the role of Tax incentive in the future.This article found through research that reducing taxes and fees can effectively incentivize high-tech enterprises to increase R&D investment,that is,the investment in R&D innovation by enterprises increases with the increase of tax incentives.However,different types of tax preferential policies have different incentive effects on enterprises,and the impact of tax reduction and fee reduction on enterprise R&D personnel and R&D risks is relatively weak.This article summarizes the incentive paths and effects of tax reduction and fee reduction on R&D investment in high-tech enterprises,establishes a comprehensive evaluation system for incentive effects,enriches research on incentive effects at the micro level,provides suggestions for the targeted improvement of relevant tax policies by the country,guides high-tech enterprises to fully utilize tax incentives to empower innovation and development,and assists in the construction of a strong technology country. |
